Independent Oversight Committee: WHO Needs Stronger Base of Finance and Authority For More Robust Pandemic Response 25/05/2021 Chandre Prince Bold decisions are required to strengthen the World Health Organization and equip it with authority and resources it needs to address glaring shortcomings in pandemic preparedness and response, the 74th World Health Assembly was told on Tuesday. Recommendations emerging out of a report by the Independent Oversight and Advisory Committee (IOAC) for the WHO Health […] Continue reading -> Smart Public Health Policies Can Help Close Health Gaps Caused By COVID-19 – And Raise Revenue 21/05/2021 Chandre Prince A sugar tax that generated R3-billion in revenue for South Africa in one year and a mandatory minimum unit price for alcohol products that contributed to a 10% decrease in alcohol-related deaths in Scotland are two examples of proven successful policies governments have adopted for products that negatively impact health and that have helped raise […] Continue reading -> Gavi Makes Deal With J&J on COVID-19 Vaccines; WHO Says COVID-19 Deaths Could Be 2-3 Times Higher Than 3.2 Million Reported 21/05/2021 Kerry Cullinan Johnson & Johnson will supply COVAX 200 million of its single-dose COVID-19 vaccines by the end of the year, according to a statement on Friday by Gavi, the Vaccine Alliance, announcing the advance purchase agreement. The vaccine will be available to both COVAX members who buy their own vaccines and the COVAX AMC members. “Today’s […] Continue reading -> As Gaza-Israel Cease-Fire Looms, WHO Officials Warn That Conflict’s Embers Could Reignite A New Wave Of COVID-19 21/05/2021 Madeleine Hoecklin The hostilities between Israel and Hamas over the past 10 days have caused significant damage to the health system in Gaza, putting the Palestinian population at risk of increased spread of COVID-19 – after six weeks in which new cases had been in sharp decline. The health system in Gaza is now facing severe shortages […] Continue reading -> ‘IP Monopoly Capitalism’ – A ‘Virus’ To Society During COVID-19 19/05/2021 Raisa Santos Governments and pharmaceutical companies alike must work together in combating the ‘virus of intellectual property (IP) monopolies over COVID-19 vaccines – which further exacerbates inequality and lack of access to vaccines for vulnerable groups. That was the uptake of a group of experts speaking at a webinar Wednesday on “The Virus of IP Monopoly Capitalism”’ […] Continue reading -> Sanofi-GSK Position SARS-CoV2 Candidate Vaccine as Potential ‘Booster’ 18/05/2021 Kerry Cullinan Sanofi and GSK will test their two-dose SARS-CoV2 vaccine candidate as a booster for other vaccines during its phase 3 trial, following a phase 2 trial that showed that it triggered a strong neutralizing antibody response in people previously vaccinated. Those who had already been vaccinated showed a strong response after one jab, indicating that […] Continue reading -> Delaying Second Pfizer COVID-19 Vaccine Dose Increases Antibody Response Threefold In Over-80s, Study Finds 14/05/2021 Madeleine Hoecklin Delaying the second dose of the Pfizer/BioNTech COVID-19 vaccine by 12 weeks could generate antibody responses in those over the age of 80 more than threefold, found a pre-print study published on Friday. The study, conducted by the University of Birmingham and Public Health England, is the first to directly compare the immune response derived […] Continue reading -> Top Scientists Call For Further Investigation Into Virus Origins Ahead Of World Health Assembly 14/05/2021 Madeleine Hoecklin A group of 18 prominent scientists, primarily based in the United States, have called for further investigations into the origins of the SARS-CoV2 virus, including that it could have been created in the Wuhan Institute of Virology lab, in a letter published on Thursday in the journal Science. The letter, organised by David Relman, Professor […] Continue reading -> Impact of COVID-19 on African Continent Underestimated, Says New Report 12/05/2021 Raisa Santos Limitations in COVID-19 testing capacity and surveillance—as well as uneven demand for testing—are likely masking the true severity of COVID-19 on the African continent, fueling the dangerous myth that much of Africa has been unscathed by COVID-19. Test positivity rates were above 10% across many African Union (AU) member states during the second wave—substantially higher […] Continue reading -> Company Pushes Canada to Grant Compulsory License for Johnson & Johnson COVID-19 Vaccine 11/05/2021 Kerry Cullinan A Canadian pharmaceutical company, Biolyse, has agreed to provide Bolivia with 15 million doses of the Johnson & Johnson COVID-19 vaccine – as long as the Canadian government gives it a compulsory license to manufacture the vaccine. In March, Johnson & Johnson rejected an application by Biolyse for a voluntary license to make a generic […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Smart Public Health Policies Can Help Close Health Gaps Caused By COVID-19 – And Raise Revenue 21/05/2021 Chandre Prince A sugar tax that generated R3-billion in revenue for South Africa in one year and a mandatory minimum unit price for alcohol products that contributed to a 10% decrease in alcohol-related deaths in Scotland are two examples of proven successful policies governments have adopted for products that negatively impact health and that have helped raise […] Continue reading -> Gavi Makes Deal With J&J on COVID-19 Vaccines; WHO Says COVID-19 Deaths Could Be 2-3 Times Higher Than 3.2 Million Reported 21/05/2021 Kerry Cullinan Johnson & Johnson will supply COVAX 200 million of its single-dose COVID-19 vaccines by the end of the year, according to a statement on Friday by Gavi, the Vaccine Alliance, announcing the advance purchase agreement. The vaccine will be available to both COVAX members who buy their own vaccines and the COVAX AMC members. “Today’s […] Continue reading -> As Gaza-Israel Cease-Fire Looms, WHO Officials Warn That Conflict’s Embers Could Reignite A New Wave Of COVID-19 21/05/2021 Madeleine Hoecklin The hostilities between Israel and Hamas over the past 10 days have caused significant damage to the health system in Gaza, putting the Palestinian population at risk of increased spread of COVID-19 – after six weeks in which new cases had been in sharp decline. The health system in Gaza is now facing severe shortages […] Continue reading -> ‘IP Monopoly Capitalism’ – A ‘Virus’ To Society During COVID-19 19/05/2021 Raisa Santos Governments and pharmaceutical companies alike must work together in combating the ‘virus of intellectual property (IP) monopolies over COVID-19 vaccines – which further exacerbates inequality and lack of access to vaccines for vulnerable groups. That was the uptake of a group of experts speaking at a webinar Wednesday on “The Virus of IP Monopoly Capitalism”’ […] Continue reading -> Sanofi-GSK Position SARS-CoV2 Candidate Vaccine as Potential ‘Booster’ 18/05/2021 Kerry Cullinan Sanofi and GSK will test their two-dose SARS-CoV2 vaccine candidate as a booster for other vaccines during its phase 3 trial, following a phase 2 trial that showed that it triggered a strong neutralizing antibody response in people previously vaccinated. Those who had already been vaccinated showed a strong response after one jab, indicating that […] Continue reading -> Delaying Second Pfizer COVID-19 Vaccine Dose Increases Antibody Response Threefold In Over-80s, Study Finds 14/05/2021 Madeleine Hoecklin Delaying the second dose of the Pfizer/BioNTech COVID-19 vaccine by 12 weeks could generate antibody responses in those over the age of 80 more than threefold, found a pre-print study published on Friday. The study, conducted by the University of Birmingham and Public Health England, is the first to directly compare the immune response derived […] Continue reading -> Top Scientists Call For Further Investigation Into Virus Origins Ahead Of World Health Assembly 14/05/2021 Madeleine Hoecklin A group of 18 prominent scientists, primarily based in the United States, have called for further investigations into the origins of the SARS-CoV2 virus, including that it could have been created in the Wuhan Institute of Virology lab, in a letter published on Thursday in the journal Science. The letter, organised by David Relman, Professor […] Continue reading -> Impact of COVID-19 on African Continent Underestimated, Says New Report 12/05/2021 Raisa Santos Limitations in COVID-19 testing capacity and surveillance—as well as uneven demand for testing—are likely masking the true severity of COVID-19 on the African continent, fueling the dangerous myth that much of Africa has been unscathed by COVID-19. Test positivity rates were above 10% across many African Union (AU) member states during the second wave—substantially higher […] Continue reading -> Company Pushes Canada to Grant Compulsory License for Johnson & Johnson COVID-19 Vaccine 11/05/2021 Kerry Cullinan A Canadian pharmaceutical company, Biolyse, has agreed to provide Bolivia with 15 million doses of the Johnson & Johnson COVID-19 vaccine – as long as the Canadian government gives it a compulsory license to manufacture the vaccine. In March, Johnson & Johnson rejected an application by Biolyse for a voluntary license to make a generic […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Gavi Makes Deal With J&J on COVID-19 Vaccines; WHO Says COVID-19 Deaths Could Be 2-3 Times Higher Than 3.2 Million Reported 21/05/2021 Kerry Cullinan Johnson & Johnson will supply COVAX 200 million of its single-dose COVID-19 vaccines by the end of the year, according to a statement on Friday by Gavi, the Vaccine Alliance, announcing the advance purchase agreement. The vaccine will be available to both COVAX members who buy their own vaccines and the COVAX AMC members. “Today’s […] Continue reading -> As Gaza-Israel Cease-Fire Looms, WHO Officials Warn That Conflict’s Embers Could Reignite A New Wave Of COVID-19 21/05/2021 Madeleine Hoecklin The hostilities between Israel and Hamas over the past 10 days have caused significant damage to the health system in Gaza, putting the Palestinian population at risk of increased spread of COVID-19 – after six weeks in which new cases had been in sharp decline. The health system in Gaza is now facing severe shortages […] Continue reading -> ‘IP Monopoly Capitalism’ – A ‘Virus’ To Society During COVID-19 19/05/2021 Raisa Santos Governments and pharmaceutical companies alike must work together in combating the ‘virus of intellectual property (IP) monopolies over COVID-19 vaccines – which further exacerbates inequality and lack of access to vaccines for vulnerable groups. That was the uptake of a group of experts speaking at a webinar Wednesday on “The Virus of IP Monopoly Capitalism”’ […] Continue reading -> Sanofi-GSK Position SARS-CoV2 Candidate Vaccine as Potential ‘Booster’ 18/05/2021 Kerry Cullinan Sanofi and GSK will test their two-dose SARS-CoV2 vaccine candidate as a booster for other vaccines during its phase 3 trial, following a phase 2 trial that showed that it triggered a strong neutralizing antibody response in people previously vaccinated. Those who had already been vaccinated showed a strong response after one jab, indicating that […] Continue reading -> Delaying Second Pfizer COVID-19 Vaccine Dose Increases Antibody Response Threefold In Over-80s, Study Finds 14/05/2021 Madeleine Hoecklin Delaying the second dose of the Pfizer/BioNTech COVID-19 vaccine by 12 weeks could generate antibody responses in those over the age of 80 more than threefold, found a pre-print study published on Friday. The study, conducted by the University of Birmingham and Public Health England, is the first to directly compare the immune response derived […] Continue reading -> Top Scientists Call For Further Investigation Into Virus Origins Ahead Of World Health Assembly 14/05/2021 Madeleine Hoecklin A group of 18 prominent scientists, primarily based in the United States, have called for further investigations into the origins of the SARS-CoV2 virus, including that it could have been created in the Wuhan Institute of Virology lab, in a letter published on Thursday in the journal Science. The letter, organised by David Relman, Professor […] Continue reading -> Impact of COVID-19 on African Continent Underestimated, Says New Report 12/05/2021 Raisa Santos Limitations in COVID-19 testing capacity and surveillance—as well as uneven demand for testing—are likely masking the true severity of COVID-19 on the African continent, fueling the dangerous myth that much of Africa has been unscathed by COVID-19. Test positivity rates were above 10% across many African Union (AU) member states during the second wave—substantially higher […] Continue reading -> Company Pushes Canada to Grant Compulsory License for Johnson & Johnson COVID-19 Vaccine 11/05/2021 Kerry Cullinan A Canadian pharmaceutical company, Biolyse, has agreed to provide Bolivia with 15 million doses of the Johnson & Johnson COVID-19 vaccine – as long as the Canadian government gives it a compulsory license to manufacture the vaccine. In March, Johnson & Johnson rejected an application by Biolyse for a voluntary license to make a generic […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
As Gaza-Israel Cease-Fire Looms, WHO Officials Warn That Conflict’s Embers Could Reignite A New Wave Of COVID-19 21/05/2021 Madeleine Hoecklin The hostilities between Israel and Hamas over the past 10 days have caused significant damage to the health system in Gaza, putting the Palestinian population at risk of increased spread of COVID-19 – after six weeks in which new cases had been in sharp decline. The health system in Gaza is now facing severe shortages […] Continue reading -> ‘IP Monopoly Capitalism’ – A ‘Virus’ To Society During COVID-19 19/05/2021 Raisa Santos Governments and pharmaceutical companies alike must work together in combating the ‘virus of intellectual property (IP) monopolies over COVID-19 vaccines – which further exacerbates inequality and lack of access to vaccines for vulnerable groups. That was the uptake of a group of experts speaking at a webinar Wednesday on “The Virus of IP Monopoly Capitalism”’ […] Continue reading -> Sanofi-GSK Position SARS-CoV2 Candidate Vaccine as Potential ‘Booster’ 18/05/2021 Kerry Cullinan Sanofi and GSK will test their two-dose SARS-CoV2 vaccine candidate as a booster for other vaccines during its phase 3 trial, following a phase 2 trial that showed that it triggered a strong neutralizing antibody response in people previously vaccinated. Those who had already been vaccinated showed a strong response after one jab, indicating that […] Continue reading -> Delaying Second Pfizer COVID-19 Vaccine Dose Increases Antibody Response Threefold In Over-80s, Study Finds 14/05/2021 Madeleine Hoecklin Delaying the second dose of the Pfizer/BioNTech COVID-19 vaccine by 12 weeks could generate antibody responses in those over the age of 80 more than threefold, found a pre-print study published on Friday. The study, conducted by the University of Birmingham and Public Health England, is the first to directly compare the immune response derived […] Continue reading -> Top Scientists Call For Further Investigation Into Virus Origins Ahead Of World Health Assembly 14/05/2021 Madeleine Hoecklin A group of 18 prominent scientists, primarily based in the United States, have called for further investigations into the origins of the SARS-CoV2 virus, including that it could have been created in the Wuhan Institute of Virology lab, in a letter published on Thursday in the journal Science. The letter, organised by David Relman, Professor […] Continue reading -> Impact of COVID-19 on African Continent Underestimated, Says New Report 12/05/2021 Raisa Santos Limitations in COVID-19 testing capacity and surveillance—as well as uneven demand for testing—are likely masking the true severity of COVID-19 on the African continent, fueling the dangerous myth that much of Africa has been unscathed by COVID-19. Test positivity rates were above 10% across many African Union (AU) member states during the second wave—substantially higher […] Continue reading -> Company Pushes Canada to Grant Compulsory License for Johnson & Johnson COVID-19 Vaccine 11/05/2021 Kerry Cullinan A Canadian pharmaceutical company, Biolyse, has agreed to provide Bolivia with 15 million doses of the Johnson & Johnson COVID-19 vaccine – as long as the Canadian government gives it a compulsory license to manufacture the vaccine. In March, Johnson & Johnson rejected an application by Biolyse for a voluntary license to make a generic […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
‘IP Monopoly Capitalism’ – A ‘Virus’ To Society During COVID-19 19/05/2021 Raisa Santos Governments and pharmaceutical companies alike must work together in combating the ‘virus of intellectual property (IP) monopolies over COVID-19 vaccines – which further exacerbates inequality and lack of access to vaccines for vulnerable groups. That was the uptake of a group of experts speaking at a webinar Wednesday on “The Virus of IP Monopoly Capitalism”’ […] Continue reading -> Sanofi-GSK Position SARS-CoV2 Candidate Vaccine as Potential ‘Booster’ 18/05/2021 Kerry Cullinan Sanofi and GSK will test their two-dose SARS-CoV2 vaccine candidate as a booster for other vaccines during its phase 3 trial, following a phase 2 trial that showed that it triggered a strong neutralizing antibody response in people previously vaccinated. Those who had already been vaccinated showed a strong response after one jab, indicating that […] Continue reading -> Delaying Second Pfizer COVID-19 Vaccine Dose Increases Antibody Response Threefold In Over-80s, Study Finds 14/05/2021 Madeleine Hoecklin Delaying the second dose of the Pfizer/BioNTech COVID-19 vaccine by 12 weeks could generate antibody responses in those over the age of 80 more than threefold, found a pre-print study published on Friday. The study, conducted by the University of Birmingham and Public Health England, is the first to directly compare the immune response derived […] Continue reading -> Top Scientists Call For Further Investigation Into Virus Origins Ahead Of World Health Assembly 14/05/2021 Madeleine Hoecklin A group of 18 prominent scientists, primarily based in the United States, have called for further investigations into the origins of the SARS-CoV2 virus, including that it could have been created in the Wuhan Institute of Virology lab, in a letter published on Thursday in the journal Science. The letter, organised by David Relman, Professor […] Continue reading -> Impact of COVID-19 on African Continent Underestimated, Says New Report 12/05/2021 Raisa Santos Limitations in COVID-19 testing capacity and surveillance—as well as uneven demand for testing—are likely masking the true severity of COVID-19 on the African continent, fueling the dangerous myth that much of Africa has been unscathed by COVID-19. Test positivity rates were above 10% across many African Union (AU) member states during the second wave—substantially higher […] Continue reading -> Company Pushes Canada to Grant Compulsory License for Johnson & Johnson COVID-19 Vaccine 11/05/2021 Kerry Cullinan A Canadian pharmaceutical company, Biolyse, has agreed to provide Bolivia with 15 million doses of the Johnson & Johnson COVID-19 vaccine – as long as the Canadian government gives it a compulsory license to manufacture the vaccine. In March, Johnson & Johnson rejected an application by Biolyse for a voluntary license to make a generic […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Sanofi-GSK Position SARS-CoV2 Candidate Vaccine as Potential ‘Booster’ 18/05/2021 Kerry Cullinan Sanofi and GSK will test their two-dose SARS-CoV2 vaccine candidate as a booster for other vaccines during its phase 3 trial, following a phase 2 trial that showed that it triggered a strong neutralizing antibody response in people previously vaccinated. Those who had already been vaccinated showed a strong response after one jab, indicating that […] Continue reading -> Delaying Second Pfizer COVID-19 Vaccine Dose Increases Antibody Response Threefold In Over-80s, Study Finds 14/05/2021 Madeleine Hoecklin Delaying the second dose of the Pfizer/BioNTech COVID-19 vaccine by 12 weeks could generate antibody responses in those over the age of 80 more than threefold, found a pre-print study published on Friday. The study, conducted by the University of Birmingham and Public Health England, is the first to directly compare the immune response derived […] Continue reading -> Top Scientists Call For Further Investigation Into Virus Origins Ahead Of World Health Assembly 14/05/2021 Madeleine Hoecklin A group of 18 prominent scientists, primarily based in the United States, have called for further investigations into the origins of the SARS-CoV2 virus, including that it could have been created in the Wuhan Institute of Virology lab, in a letter published on Thursday in the journal Science. The letter, organised by David Relman, Professor […] Continue reading -> Impact of COVID-19 on African Continent Underestimated, Says New Report 12/05/2021 Raisa Santos Limitations in COVID-19 testing capacity and surveillance—as well as uneven demand for testing—are likely masking the true severity of COVID-19 on the African continent, fueling the dangerous myth that much of Africa has been unscathed by COVID-19. Test positivity rates were above 10% across many African Union (AU) member states during the second wave—substantially higher […] Continue reading -> Company Pushes Canada to Grant Compulsory License for Johnson & Johnson COVID-19 Vaccine 11/05/2021 Kerry Cullinan A Canadian pharmaceutical company, Biolyse, has agreed to provide Bolivia with 15 million doses of the Johnson & Johnson COVID-19 vaccine – as long as the Canadian government gives it a compulsory license to manufacture the vaccine. In March, Johnson & Johnson rejected an application by Biolyse for a voluntary license to make a generic […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Delaying Second Pfizer COVID-19 Vaccine Dose Increases Antibody Response Threefold In Over-80s, Study Finds 14/05/2021 Madeleine Hoecklin Delaying the second dose of the Pfizer/BioNTech COVID-19 vaccine by 12 weeks could generate antibody responses in those over the age of 80 more than threefold, found a pre-print study published on Friday. The study, conducted by the University of Birmingham and Public Health England, is the first to directly compare the immune response derived […] Continue reading -> Top Scientists Call For Further Investigation Into Virus Origins Ahead Of World Health Assembly 14/05/2021 Madeleine Hoecklin A group of 18 prominent scientists, primarily based in the United States, have called for further investigations into the origins of the SARS-CoV2 virus, including that it could have been created in the Wuhan Institute of Virology lab, in a letter published on Thursday in the journal Science. The letter, organised by David Relman, Professor […] Continue reading -> Impact of COVID-19 on African Continent Underestimated, Says New Report 12/05/2021 Raisa Santos Limitations in COVID-19 testing capacity and surveillance—as well as uneven demand for testing—are likely masking the true severity of COVID-19 on the African continent, fueling the dangerous myth that much of Africa has been unscathed by COVID-19. Test positivity rates were above 10% across many African Union (AU) member states during the second wave—substantially higher […] Continue reading -> Company Pushes Canada to Grant Compulsory License for Johnson & Johnson COVID-19 Vaccine 11/05/2021 Kerry Cullinan A Canadian pharmaceutical company, Biolyse, has agreed to provide Bolivia with 15 million doses of the Johnson & Johnson COVID-19 vaccine – as long as the Canadian government gives it a compulsory license to manufacture the vaccine. In March, Johnson & Johnson rejected an application by Biolyse for a voluntary license to make a generic […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Top Scientists Call For Further Investigation Into Virus Origins Ahead Of World Health Assembly 14/05/2021 Madeleine Hoecklin A group of 18 prominent scientists, primarily based in the United States, have called for further investigations into the origins of the SARS-CoV2 virus, including that it could have been created in the Wuhan Institute of Virology lab, in a letter published on Thursday in the journal Science. The letter, organised by David Relman, Professor […] Continue reading -> Impact of COVID-19 on African Continent Underestimated, Says New Report 12/05/2021 Raisa Santos Limitations in COVID-19 testing capacity and surveillance—as well as uneven demand for testing—are likely masking the true severity of COVID-19 on the African continent, fueling the dangerous myth that much of Africa has been unscathed by COVID-19. Test positivity rates were above 10% across many African Union (AU) member states during the second wave—substantially higher […] Continue reading -> Company Pushes Canada to Grant Compulsory License for Johnson & Johnson COVID-19 Vaccine 11/05/2021 Kerry Cullinan A Canadian pharmaceutical company, Biolyse, has agreed to provide Bolivia with 15 million doses of the Johnson & Johnson COVID-19 vaccine – as long as the Canadian government gives it a compulsory license to manufacture the vaccine. In March, Johnson & Johnson rejected an application by Biolyse for a voluntary license to make a generic […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Impact of COVID-19 on African Continent Underestimated, Says New Report 12/05/2021 Raisa Santos Limitations in COVID-19 testing capacity and surveillance—as well as uneven demand for testing—are likely masking the true severity of COVID-19 on the African continent, fueling the dangerous myth that much of Africa has been unscathed by COVID-19. Test positivity rates were above 10% across many African Union (AU) member states during the second wave—substantially higher […] Continue reading -> Company Pushes Canada to Grant Compulsory License for Johnson & Johnson COVID-19 Vaccine 11/05/2021 Kerry Cullinan A Canadian pharmaceutical company, Biolyse, has agreed to provide Bolivia with 15 million doses of the Johnson & Johnson COVID-19 vaccine – as long as the Canadian government gives it a compulsory license to manufacture the vaccine. In March, Johnson & Johnson rejected an application by Biolyse for a voluntary license to make a generic […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Company Pushes Canada to Grant Compulsory License for Johnson & Johnson COVID-19 Vaccine 11/05/2021 Kerry Cullinan A Canadian pharmaceutical company, Biolyse, has agreed to provide Bolivia with 15 million doses of the Johnson & Johnson COVID-19 vaccine – as long as the Canadian government gives it a compulsory license to manufacture the vaccine. In March, Johnson & Johnson rejected an application by Biolyse for a voluntary license to make a generic […] Continue reading -> Posts navigation Older postsNewer posts